US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
Patent 11472791 was granted and assigned to Incyte on October, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
